C4 Therapeutics, Inc. (CCCC) reporting calendar
C4 Therapeutics, Inc. files periodic reports with the SEC as CCCC on Nasdaq. Atlas tracks 23 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 24 Jul 2026 – 19 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 12 May 2026
- Reports on record
- 23
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open CCCC market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 12 May 2026 | 42 days | 0001628280-26-033865 |
| 10-K | 31 Dec 2025 | 26 Feb 2026 | 57 days | 0001628280-26-012000 |
| 10-Q | 30 Sep 2025 | 6 Nov 2025 | 37 days | 0001628280-25-049854 |
| 10-Q | 30 Jun 2025 | 7 Aug 2025 | 38 days | 0001628280-25-038587 |
| 10-Q | 31 Mar 2025 | 7 May 2025 | 37 days | 0001628280-25-022866 |
| 10-K | 31 Dec 2024 | 27 Feb 2025 | 58 days | 0001628280-25-008433 |
| 10-Q | 30 Sep 2024 | 31 Oct 2024 | 31 days | 0001628280-24-044411 |
| 10-Q | 30 Jun 2024 | 1 Aug 2024 | 32 days | 0001628280-24-033882 |
| 10-Q | 31 Mar 2024 | 8 May 2024 | 38 days | 0001628280-24-021368 |
| 10-K | 31 Dec 2023 | 22 Feb 2024 | 53 days | 0001628280-24-006144 |
| 10-Q | 30 Sep 2023 | 1 Nov 2023 | 32 days | 0001628280-23-035793 |
| 10-Q | 30 Jun 2023 | 8 Aug 2023 | 39 days | 0001628280-23-027941 |
| 10-Q | 31 Mar 2023 | 4 May 2023 | 34 days | 0001628280-23-015459 |
| 10-K | 31 Dec 2022 | 23 Feb 2023 | 54 days | 0001628280-23-004711 |
| 10-Q | 30 Sep 2022 | 3 Nov 2022 | 34 days | 0001628280-22-027985 |
| 10-Q | 30 Jun 2022 | 4 Aug 2022 | 35 days | 0001628280-22-020886 |
| 10-Q | 31 Mar 2022 | 5 May 2022 | 35 days | 0001564590-22-018046 |
| 10-K | 31 Dec 2021 | 24 Feb 2022 | 55 days | 0001564590-22-006499 |
| 10-Q | 30 Sep 2021 | 10 Nov 2021 | 41 days | 0001564590-21-056223 |
| 10-Q | 30 Jun 2021 | 11 Aug 2021 | 42 days | 0001564590-21-043442 |
| 10-Q | 31 Mar 2021 | 13 May 2021 | 43 days | 0001564590-21-027606 |
| 10-K | 31 Dec 2020 | 11 Mar 2021 | 70 days | 0001564590-21-012531 |
| 10-Q | 30 Sep 2020 | 12 Nov 2020 | 43 days | 0001564590-20-053604 |
Source: SEC EDGAR company submissions for CIK 0001662579. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.